Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug/Agent Toxicity by Tissue/Organ”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Testing effectiveness (Phase 2)Study completedNCT00055718
What this trial is testing

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Herbert Irving Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Cancer Center at Thomas Jefferson University
Post-approval studies (Phase 4)WithdrawnNCT01374061
What this trial is testing

Pre Hospital Evaluation of Video Laryngoscopy

Who this might be right for
Cardiac ArrestRespiratory Distress SyndromeShock+3 more
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT02278432
What this trial is testing

Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo Brasiliense

Who this might be right for
Omeprazole
Universidade Estadual Paulista Júlio de Mesquita Filho 427
Large-scale testing (Phase 3)Study completedNCT00017004
What this trial is testing

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Who this might be right for
AnemiaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+6 more
Gynecologic Oncology Group 114
Not applicableStudy completedNCT01861262
What this trial is testing

StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning

Who this might be right for
Drug Poisoning
University Hospital, Toulouse 300
Not applicableUnknownNCT05564923
What this trial is testing

CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab

Who this might be right for
Nivolumab Related Toxicity
Namik Kemal University 100
Not applicableEnded earlyNCT02889042
What this trial is testing

Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging

Who this might be right for
Volunteers Repeated Drug PoisoningAlcoholicVolunteers
University Hospital, Grenoble 1
Not applicableStudy completedNCT03882541
What this trial is testing

Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia?

Who this might be right for
AnxietySurgeryDrug Toxicity+2 more
Consorci Sanitari de l'Anoia 85
Testing effectiveness (Phase 2)UnknownNCT00003583
What this trial is testing

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
University of Florida 20
Not applicableStudy completedNCT04275024
What this trial is testing

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 8
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Large-scale testing (Phase 3)Study completedNCT00003313
What this trial is testing

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerOral Complications+1 more
Radiation Therapy Oncology Group 243
Early research (Phase 1)Study completedNCT00093353
What this trial is testing

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Who this might be right for
DiarrheaDrug/Agent Toxicity by Tissue/OrganNeuroblastoma
Children's Hospital Los Angeles 30
Not applicableStudy completedNCT02770339
What this trial is testing

Pharmacogenomic Profiling of Pediatric Patients

Who this might be right for
Mental DisordersMetabolism Medication ToxicityPediatric Disorder
University of Alabama at Birmingham 100
Not applicableUnknownNCT04400786
What this trial is testing

Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

Who this might be right for
Ankylosing SpondylitisTherapeutic Agent Toxicity
Shanghai Zhongshan Hospital 196
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Load More Results